Landmark Clinical Study Validates Patch-Based Onera Home-Polysomnography System in One of the Largest Sleep Diagnostic Trials of the Decade
Onera Health, a leader in transforming sleep medicine and remote monitoring, today announced the publication of a multicenter validation study of its Onera Sleep Test System (STS) in the Journal of Clinical Sleep Medicine, the official journal of the American Academy of Sleep Medicine. The study demonstrated that the patch-based Onera STS home-polysomnography (hPSG) performs comparably to gold-standard in-lab polysomnography (PSG) for both sleep staging and respiratory event detection.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250113111691/en/
A woman is conducting a sleep test (polysomnography) using the patch-based Onera STS hPSG system. (Photo: Business Wire)
The international multicenter study was managed by an independent Clinical Research Organization and involved the analysis of 206 participants across seven clinical sites in Germany and a US-based core laboratory at Johns Hopkins University. The study found high concordance between the Onera STS and traditional PSG across essential sleep variables and key respiratory parameters, as well as substantial epoch-by-epoch agreement in sleep staging and comparable inter-scorer reliability between the two systems, which is essential for physicians to make accurate diagnoses and treatment decisions in sleep medicine.
"Our rigorous multicenter validation study provides robust evidence that the Onera Sleep Test System performs comparably to traditional in-lab polysomnography for sleep staging and respiratory event detection," said Dr. Christian Viniol, MD, Ph. D, lead author and Head of Sleep Medicine at University Hospital Marburg, Germany. "This validation is crucial as we face increasing demand for sleep studies alongside increasing resource constraints. The proven accuracy of Onera’s product will significantly improve access to comprehensive sleep diagnostics, potentially transforming our approach to diagnosing and treating sleep disorders on a larger scale."
"We are thrilled with the successful completion of this comprehensive validation study," said Ruben de Francisco, Founder and CEO of Onera Health. "This validation is a critical milestone in our mission to make the gold-standard sleep test, polysomnography or PSG, available at the patient’s home. The results clearly demonstrate that our innovative, patch-based technology can deliver the level of accuracy needed for a comprehensive hPSG sleep test, with an accuracy that is equivalent to that of traditional in-lab PSG."
"These results represent an important milestone in our journey toward more accessible and personalized sleep medicine. The Onera technology enables high-quality sleep assessment in the patient's natural environment, opening new possibilities for longitudinal monitoring and improved assessment of treatment outcomes. This capability may fundamentally transform the future of sleep disorder diagnosis and treatment evaluation in the future," added Dr. David P. White, Professor of Medicine, Part Time at Harvard Medical School, Boston, United States, and Member of the Medical Advisory Board at Onera Health.
The wireless, patch-based Onera STS hPSG addresses critical challenges in sleep medicine by providing a viable alternative to traditional in-lab polysomnography. Its comparable performance in sleep staging and respiratory event detection, coupled with simplified application, significantly increases access to high-quality, comprehensive sleep assessments.
This landmark validation study is part of Onera Health's comprehensive clinical evidence generation program, demonstrating the commitment to rigorous scientific validation of Onera’s technology. Additional studies are currently ongoing across multiple centers and healthcare settings, which will further validate the clinical utility and real-world impact of Onera’s home Polysomnography solution. This evidence generation strategy reflects Onera’s dedication to advancing sleep medicine through high-quality clinical research.
The study, entitled 'Clinical validation of a wireless patch-based polysomnography system', is published in the Journal of Clinical Sleep Medicine and can be accessed online at https://jcsm.aasm.org/doi/10.5664/jcsm.11524.
About Onera
Onera Health is a leader in transforming sleep medicine and remote monitoring. Their breakthrough diagnostic solutions and services are poised to help millions of people struggling with sleep-related ailments while also impacting other medical fields by monitoring various chronic conditions, ultimately improving the health and quality of life of patients worldwide. The company’s innovative solutions provide comprehensive sleep test data to physicians in a variety of clinical and non-clinical environments to optimize patient care and reduce healthcare costs. Onera has offices in the Netherlands and the U.S. For more information, go to onerahealth.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20250113111691/en/
Contacts
For additional information or media inquiries, please contact:
Swea Ann Hagenhoff
Sr. Branding and Communications Specialist
Onera Health
media@onerahealth.com
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
“UNESCO For The People”: Khaled El-Enany Unveils His Campaign Slogan for the Position of Director-General of UNESCO14.1.2025 12:28:00 CET | Press Release
This press release is issued by the Egyptian Campaign for the Post of Director-General of UNESCO. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250114334927/en/ (Photo: Business Wire) Khaled El-Enany, a renowned Egyptologist and former Minister of Tourism and Antiquities, unveiled his campaign slogan for the position of Director-General of UNESCO: “UNESCO for the People.” The announcement was made during a grand gathering held at the National Museum of Egyptian Civilization on January 13, attended by ambassadors from over 100 countries, representatives of international organizations, and prominent figures from the political, academic, and cultural spheres. This event provided a unique platform to outline the initial pillars of Khaled El-Enany’s vision, which aims to make UNESCO a true institution for the people. He highlighted the urgency of adapting the organization to 21st-century realities by addressing global challenges
Rawbank Conducts a USD 10 Million Commercial Paper to Support the Mining Industry and Strengthen the Congolese Economy14.1.2025 11:52:00 CET | Press Release
Rawbank, the leading bank in the Democratic Republic of Congo, announces the launch of its second issue of commercial paper for a local mining operator in the Katanga region for the sum of USD 10 million. This transaction, arranged by Rawbank's trading room, confirms the bank's role as a key player in financial innovation in the DRC, while satisfying the strategic financing needs of companies operating in major sectors of the national economy. Following the success of its first issuance in 2022, which marked a significant step forward for the financial market in the Democratic Republic of Congo, Rawbank has affirmed its pioneering role by introducing solutions that are ever-increasingly adapted to local conditions. A major innovation in this issuance is the inclusion of a corporate guarantee - a first in the DRC - which strengthens investor security and extends the financing options available on the money market. This transaction was approved by the Central Bank of the Congo (CBC) unde
Infobip is One of the Top CPaaS Providers in Metrigy’s CPaaS MetriRank Report14.1.2025 10:43:00 CET | Press Release
Global communications platformInfobiphas been ranked as the second-highest scoring Communications Platform as a Service (CPaaS) provider in analyst firm Metrigy’s latest CPaaS MetriRank Report. Infobip stands out for its stellar product mix and outstanding customer sentiment and customer business success scores, confirming its status as a CPaaS market leader. The 2024 MetriRank CPaaS report ranks the top players by market share in the global CPaaS market, comparing financials, market share momentum, product mix, customer sentiment, and customer business success. Infobip is recognized by Metrigy for its expanding go-to-market strategy, self-service capabilities and CPaaS ecosystem partnerships.Infobip scored maximum points for product mix, with a strong portfolio that includes not only a full range of communications APIs, but also CPaaS X, AI-powered omnichannel solutions, and other innovative offerings. Further, Metrigy noted Infobip also delivers high-value projects and follow-on prof
Sodali & Co Appoints Andrew Benett as Chief Executive Officer14.1.2025 10:00:00 CET | Press Release
Sodali & Co (the ‘firm’ or ‘Sodali’ and formerly Morrow Sodali), a leading global advisory firm, is pleased to announce the appointment of Andrew Benett as Chief Executive Officer, effective immediately. He will be based in New York. Andrew has a 30-year career across global advisory businesses including Global CEO and Chief Strategy Officer at Havas Creative Group, Chief Commercial Officer of Bloomberg Media and CEO and Executive Chair of Harte Hanks Inc., the NASDAQ-listed publishing company. Most recently, Andrew was a Partner at PwC working with clients to deliver organic and inorganic growth, as well as leading corporate strategy initiatives for the firm. He is an acknowledged strategist, author of three business books, and a fellow of the Aspen Institute. Andrew was appointed after a global search following Alvise Recchi stepping down as CEO last September. He joins the firm at an important moment in its development. In the last two years, Sodali has transformed at speed from a s
Bioptimus Hits $76M Funding Milestone and Prepares to Launch Groundbreaking Foundation Model for Biology14.1.2025 10:00:00 CET | Press Release
Bioptimus, the pioneering AI foundation model company, announced today that it has reached a significant funding milestone of $76 million. This total includes a $41 million cash injection, led by Cathay Innovation with participation from prominent investors, including Sofinnova Partners, Bpifrance through its Large Venture Fund, Andera Partners, Hitachi Ventures, Boom Capital Ventures, Pomifer Capital, Sunrise, and angel entrepreneurs Emmanuel Cassimatis and Thomas Wolf. The funding will accelerate Bioptimus’s mission to build the world’s first universal AI foundation model for biology, aimed at revolutionizing research and innovation across the medical, biotech, cosmetic industries, and beyond. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250114054102/en/ The company has been building momentum this year, assembling a world-class team, securing access to unique data sources, and successfully releasing its first model, H-Op
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom